Common diabetes drug fails to improve walking performance in peripheral artery disease patients

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, according to results from a major U.S. clinical trial published in JAMA.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup